Quick Takeaways
- Sofinnova Crossover I filed SCHEDULE 13D/A for Abivax S.A. Ordinary Shares, par value EUR0.01 per share (ABVX).
- Disclosed ownership: 7.7%.
- Date of event: 12 Jan 2026.
Quoteable Key Fact
"Sofinnova Crossover I disclosed 7.7% ownership in Abivax S.A. Ordinary Shares, par value EUR0.01 per share (ABVX) on 12 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I SLP | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Antoine Papiernik | Managing Partner | 0001845105 |
| Sofinnova Partners SAS | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Antoine Papiernik | Managing Partner | 0001574139 |
| Antoine Papiernik | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Antoine Papiernik | Antoine Papiernik | |
| Cedric Moreau | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Cedric Moreau | Cedric Moreau | |
| Kinam Hong | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Kinam Hong | Kinam Hong | |
| Joseph Anderson | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Joseph Anderson | Joseph Anderson | |
| Jacques Theurillat | 7.7% | 6,399,478 | 6,399,478 | 0 | /s/ Jacques Theurillat | Jacques Theurillat |